nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferoxamine—Chromatopsia—Citalopram—alcohol dependence	0.0561	0.0561	CcSEcCtD
Deferoxamine—Optic neuritis—Disulfiram—alcohol dependence	0.0418	0.0418	CcSEcCtD
Deferoxamine—Night blindness—Citalopram—alcohol dependence	0.0322	0.0322	CcSEcCtD
Deferoxamine—Tonic-clonic seizures—Citalopram—alcohol dependence	0.0282	0.0282	CcSEcCtD
Deferoxamine—Induration—Naltrexone—alcohol dependence	0.0268	0.0268	CcSEcCtD
Deferoxamine—Neuropathy—Disulfiram—alcohol dependence	0.0242	0.0242	CcSEcCtD
Deferoxamine—Local swelling—Citalopram—alcohol dependence	0.0217	0.0217	CcSEcCtD
Deferoxamine—Chromaturia—Citalopram—alcohol dependence	0.0213	0.0213	CcSEcCtD
Deferoxamine—Pyelonephritis—Citalopram—alcohol dependence	0.02	0.02	CcSEcCtD
Deferoxamine—Grand mal convulsion—Citalopram—alcohol dependence	0.016	0.016	CcSEcCtD
Deferoxamine—Abdominal discomfort—Disulfiram—alcohol dependence	0.0155	0.0155	CcSEcCtD
Deferoxamine—Injection site pain—Naltrexone—alcohol dependence	0.0147	0.0147	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Disulfiram—alcohol dependence	0.0141	0.0141	CcSEcCtD
Deferoxamine—Injection site reaction—Naltrexone—alcohol dependence	0.0119	0.0119	CcSEcCtD
Deferoxamine—Aphasia—Citalopram—alcohol dependence	0.0117	0.0117	CcSEcCtD
Deferoxamine—Cramps of lower extremities—Acamprosate—alcohol dependence	0.0116	0.0116	CcSEcCtD
Deferoxamine—Cyanosis—Citalopram—alcohol dependence	0.0107	0.0107	CcSEcCtD
Deferoxamine—Delusion—Citalopram—alcohol dependence	0.0107	0.0107	CcSEcCtD
Deferoxamine—Scotoma—Citalopram—alcohol dependence	0.01	0.01	CcSEcCtD
Deferoxamine—Renal failure acute—Acamprosate—alcohol dependence	0.00996	0.00996	CcSEcCtD
Deferoxamine—Swelling—Naltrexone—alcohol dependence	0.00987	0.00987	CcSEcCtD
Deferoxamine—Blood creatinine increased—Acamprosate—alcohol dependence	0.00862	0.00862	CcSEcCtD
Deferoxamine—Bone disorder—Citalopram—alcohol dependence	0.00841	0.00841	CcSEcCtD
Deferoxamine—Paraesthesia—Disulfiram—alcohol dependence	0.00824	0.00824	CcSEcCtD
Deferoxamine—Cataract—Citalopram—alcohol dependence	0.00798	0.00798	CcSEcCtD
Deferoxamine—Asthma—Acamprosate—alcohol dependence	0.00795	0.00795	CcSEcCtD
Deferoxamine—Bone pain—Citalopram—alcohol dependence	0.00793	0.00793	CcSEcCtD
Deferoxamine—Eosinophilia—Acamprosate—alcohol dependence	0.00787	0.00787	CcSEcCtD
Deferoxamine—Pain—Disulfiram—alcohol dependence	0.00785	0.00785	CcSEcCtD
Deferoxamine—Abdominal discomfort—Naltrexone—alcohol dependence	0.00721	0.00721	CcSEcCtD
Deferoxamine—Neuropathy—Citalopram—alcohol dependence	0.00713	0.00713	CcSEcCtD
Deferoxamine—Cramps of lower extremities—Citalopram—alcohol dependence	0.00698	0.00698	CcSEcCtD
Deferoxamine—Infestation NOS—Naltrexone—alcohol dependence	0.00671	0.00671	CcSEcCtD
Deferoxamine—Infestation—Naltrexone—alcohol dependence	0.00671	0.00671	CcSEcCtD
Deferoxamine—Hallucination—Acamprosate—alcohol dependence	0.00633	0.00633	CcSEcCtD
Deferoxamine—Visual impairment—Acamprosate—alcohol dependence	0.00613	0.00613	CcSEcCtD
Deferoxamine—Dizziness—Disulfiram—alcohol dependence	0.00607	0.00607	CcSEcCtD
Deferoxamine—Hallucination—Naltrexone—alcohol dependence	0.00599	0.00599	CcSEcCtD
Deferoxamine—Renal failure acute—Citalopram—alcohol dependence	0.00597	0.00597	CcSEcCtD
Deferoxamine—Tinnitus—Acamprosate—alcohol dependence	0.00593	0.00593	CcSEcCtD
Deferoxamine—Connective tissue disorder—Naltrexone—alcohol dependence	0.00592	0.00592	CcSEcCtD
Deferoxamine—Visual disturbance—Citalopram—alcohol dependence	0.00582	0.00582	CcSEcCtD
Deferoxamine—Headache—Disulfiram—alcohol dependence	0.00575	0.00575	CcSEcCtD
Deferoxamine—Immune system disorder—Acamprosate—alcohol dependence	0.00575	0.00575	CcSEcCtD
Deferoxamine—Eye disorder—Naltrexone—alcohol dependence	0.00563	0.00563	CcSEcCtD
Deferoxamine—Tinnitus—Naltrexone—alcohol dependence	0.00561	0.00561	CcSEcCtD
Deferoxamine—Angiopathy—Naltrexone—alcohol dependence	0.00546	0.00546	CcSEcCtD
Deferoxamine—Immune system disorder—Naltrexone—alcohol dependence	0.00544	0.00544	CcSEcCtD
Deferoxamine—Mediastinal disorder—Naltrexone—alcohol dependence	0.00543	0.00543	CcSEcCtD
Deferoxamine—Muscle spasms—Acamprosate—alcohol dependence	0.00533	0.00533	CcSEcCtD
Deferoxamine—Angioedema—Acamprosate—alcohol dependence	0.00506	0.00506	CcSEcCtD
Deferoxamine—Muscle spasms—Naltrexone—alcohol dependence	0.00504	0.00504	CcSEcCtD
Deferoxamine—Leukopenia—Acamprosate—alcohol dependence	0.00496	0.00496	CcSEcCtD
Deferoxamine—Vision blurred—Naltrexone—alcohol dependence	0.00494	0.00494	CcSEcCtD
Deferoxamine—Convulsion—Acamprosate—alcohol dependence	0.0048	0.0048	CcSEcCtD
Deferoxamine—Angioedema—Naltrexone—alcohol dependence	0.00479	0.00479	CcSEcCtD
Deferoxamine—Asthma—Citalopram—alcohol dependence	0.00477	0.00477	CcSEcCtD
Deferoxamine—Eosinophilia—Citalopram—alcohol dependence	0.00472	0.00472	CcSEcCtD
Deferoxamine—Myalgia—Acamprosate—alcohol dependence	0.00472	0.00472	CcSEcCtD
Deferoxamine—Arthralgia—Acamprosate—alcohol dependence	0.00472	0.00472	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00468	0.00468	CcSEcCtD
Deferoxamine—Abdominal discomfort—Citalopram—alcohol dependence	0.00457	0.00457	CcSEcCtD
Deferoxamine—Convulsion—Naltrexone—alcohol dependence	0.00454	0.00454	CcSEcCtD
Deferoxamine—Anaphylactic shock—Acamprosate—alcohol dependence	0.00452	0.00452	CcSEcCtD
Deferoxamine—Infection—Acamprosate—alcohol dependence	0.00449	0.00449	CcSEcCtD
Deferoxamine—Myalgia—Naltrexone—alcohol dependence	0.00446	0.00446	CcSEcCtD
Deferoxamine—Arthralgia—Naltrexone—alcohol dependence	0.00446	0.00446	CcSEcCtD
Deferoxamine—Dysuria—Citalopram—alcohol dependence	0.00446	0.00446	CcSEcCtD
Deferoxamine—Shock—Acamprosate—alcohol dependence	0.00445	0.00445	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00443	0.00443	CcSEcCtD
Deferoxamine—Thrombocytopenia—Acamprosate—alcohol dependence	0.00443	0.00443	CcSEcCtD
Deferoxamine—Tachycardia—Acamprosate—alcohol dependence	0.00441	0.00441	CcSEcCtD
Deferoxamine—Skin disorder—Acamprosate—alcohol dependence	0.00439	0.00439	CcSEcCtD
Deferoxamine—Anaphylactic shock—Naltrexone—alcohol dependence	0.00428	0.00428	CcSEcCtD
Deferoxamine—Oedema—Naltrexone—alcohol dependence	0.00428	0.00428	CcSEcCtD
Deferoxamine—Infection—Naltrexone—alcohol dependence	0.00425	0.00425	CcSEcCtD
Deferoxamine—Infestation—Citalopram—alcohol dependence	0.00425	0.00425	CcSEcCtD
Deferoxamine—Infestation NOS—Citalopram—alcohol dependence	0.00425	0.00425	CcSEcCtD
Deferoxamine—Hypotension—Acamprosate—alcohol dependence	0.00422	0.00422	CcSEcCtD
Deferoxamine—Shock—Naltrexone—alcohol dependence	0.00421	0.00421	CcSEcCtD
Deferoxamine—Nervous system disorder—Naltrexone—alcohol dependence	0.0042	0.0042	CcSEcCtD
Deferoxamine—Tachycardia—Naltrexone—alcohol dependence	0.00417	0.00417	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Citalopram—alcohol dependence	0.00417	0.00417	CcSEcCtD
Deferoxamine—Skin disorder—Naltrexone—alcohol dependence	0.00416	0.00416	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00412	0.00412	CcSEcCtD
Deferoxamine—Paraesthesia—Acamprosate—alcohol dependence	0.00406	0.00406	CcSEcCtD
Deferoxamine—Dyspnoea—Acamprosate—alcohol dependence	0.00403	0.00403	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.0039	0.0039	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.0039	0.0039	CcSEcCtD
Deferoxamine—Bradycardia—Citalopram—alcohol dependence	0.00388	0.00388	CcSEcCtD
Deferoxamine—Pain—Acamprosate—alcohol dependence	0.00387	0.00387	CcSEcCtD
Deferoxamine—Paraesthesia—Naltrexone—alcohol dependence	0.00384	0.00384	CcSEcCtD
Deferoxamine—Dyspnoea—Naltrexone—alcohol dependence	0.00381	0.00381	CcSEcCtD
Deferoxamine—Hallucination—Citalopram—alcohol dependence	0.0038	0.0038	CcSEcCtD
Deferoxamine—Urinary tract disorder—Citalopram—alcohol dependence	0.00377	0.00377	CcSEcCtD
Deferoxamine—Connective tissue disorder—Citalopram—alcohol dependence	0.00375	0.00375	CcSEcCtD
Deferoxamine—Urethral disorder—Citalopram—alcohol dependence	0.00374	0.00374	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Acamprosate—alcohol dependence	0.0037	0.0037	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00369	0.00369	CcSEcCtD
Deferoxamine—Visual impairment—Citalopram—alcohol dependence	0.00368	0.00368	CcSEcCtD
Deferoxamine—Pain—Naltrexone—alcohol dependence	0.00366	0.00366	CcSEcCtD
Deferoxamine—Urticaria—Acamprosate—alcohol dependence	0.00359	0.00359	CcSEcCtD
Deferoxamine—Abdominal pain—Acamprosate—alcohol dependence	0.00357	0.00357	CcSEcCtD
Deferoxamine—Body temperature increased—Acamprosate—alcohol dependence	0.00357	0.00357	CcSEcCtD
Deferoxamine—Eye disorder—Citalopram—alcohol dependence	0.00357	0.00357	CcSEcCtD
Deferoxamine—Tinnitus—Citalopram—alcohol dependence	0.00356	0.00356	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Naltrexone—alcohol dependence	0.0035	0.0035	CcSEcCtD
Deferoxamine—Angiopathy—Citalopram—alcohol dependence	0.00346	0.00346	CcSEcCtD
Deferoxamine—Immune system disorder—Citalopram—alcohol dependence	0.00345	0.00345	CcSEcCtD
Deferoxamine—Mediastinal disorder—Citalopram—alcohol dependence	0.00344	0.00344	CcSEcCtD
Deferoxamine—Arrhythmia—Citalopram—alcohol dependence	0.00341	0.00341	CcSEcCtD
Deferoxamine—Urticaria—Naltrexone—alcohol dependence	0.0034	0.0034	CcSEcCtD
Deferoxamine—Abdominal pain—Naltrexone—alcohol dependence	0.00338	0.00338	CcSEcCtD
Deferoxamine—Body temperature increased—Naltrexone—alcohol dependence	0.00338	0.00338	CcSEcCtD
Deferoxamine—Hypersensitivity—Acamprosate—alcohol dependence	0.00333	0.00333	CcSEcCtD
Deferoxamine—Erythema—Citalopram—alcohol dependence	0.00332	0.00332	CcSEcCtD
Deferoxamine—Pruritus—Acamprosate—alcohol dependence	0.0032	0.0032	CcSEcCtD
Deferoxamine—Muscle spasms—Citalopram—alcohol dependence	0.00319	0.00319	CcSEcCtD
Deferoxamine—Hypersensitivity—Naltrexone—alcohol dependence	0.00315	0.00315	CcSEcCtD
Deferoxamine—Vision blurred—Citalopram—alcohol dependence	0.00313	0.00313	CcSEcCtD
Deferoxamine—Diarrhoea—Acamprosate—alcohol dependence	0.00309	0.00309	CcSEcCtD
Deferoxamine—Angioedema—Citalopram—alcohol dependence	0.00303	0.00303	CcSEcCtD
Deferoxamine—Pruritus—Naltrexone—alcohol dependence	0.00303	0.00303	CcSEcCtD
Deferoxamine—Dizziness—Acamprosate—alcohol dependence	0.00299	0.00299	CcSEcCtD
Deferoxamine—Leukopenia—Citalopram—alcohol dependence	0.00297	0.00297	CcSEcCtD
Deferoxamine—Diarrhoea—Naltrexone—alcohol dependence	0.00293	0.00293	CcSEcCtD
Deferoxamine—Convulsion—Citalopram—alcohol dependence	0.00288	0.00288	CcSEcCtD
Deferoxamine—Vomiting—Acamprosate—alcohol dependence	0.00287	0.00287	CcSEcCtD
Deferoxamine—Headache—Acamprosate—alcohol dependence	0.00283	0.00283	CcSEcCtD
Deferoxamine—Dizziness—Naltrexone—alcohol dependence	0.00283	0.00283	CcSEcCtD
Deferoxamine—Arthralgia—Citalopram—alcohol dependence	0.00283	0.00283	CcSEcCtD
Deferoxamine—Myalgia—Citalopram—alcohol dependence	0.00283	0.00283	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.00281	0.00281	CcSEcCtD
Deferoxamine—Vomiting—Naltrexone—alcohol dependence	0.00272	0.00272	CcSEcCtD
Deferoxamine—Oedema—Citalopram—alcohol dependence	0.00271	0.00271	CcSEcCtD
Deferoxamine—Anaphylactic shock—Citalopram—alcohol dependence	0.00271	0.00271	CcSEcCtD
Deferoxamine—Infection—Citalopram—alcohol dependence	0.00269	0.00269	CcSEcCtD
Deferoxamine—Nausea—Acamprosate—alcohol dependence	0.00269	0.00269	CcSEcCtD
Deferoxamine—Headache—Naltrexone—alcohol dependence	0.00268	0.00268	CcSEcCtD
Deferoxamine—Shock—Citalopram—alcohol dependence	0.00267	0.00267	CcSEcCtD
Deferoxamine—Nervous system disorder—Citalopram—alcohol dependence	0.00266	0.00266	CcSEcCtD
Deferoxamine—Thrombocytopenia—Citalopram—alcohol dependence	0.00265	0.00265	CcSEcCtD
Deferoxamine—Tachycardia—Citalopram—alcohol dependence	0.00265	0.00265	CcSEcCtD
Deferoxamine—Skin disorder—Citalopram—alcohol dependence	0.00263	0.00263	CcSEcCtD
Deferoxamine—Nausea—Naltrexone—alcohol dependence	0.00254	0.00254	CcSEcCtD
Deferoxamine—Hypotension—Citalopram—alcohol dependence	0.00253	0.00253	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.00247	0.00247	CcSEcCtD
Deferoxamine—Paraesthesia—Citalopram—alcohol dependence	0.00243	0.00243	CcSEcCtD
Deferoxamine—Dyspnoea—Citalopram—alcohol dependence	0.00242	0.00242	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00234	0.00234	CcSEcCtD
Deferoxamine—Pain—Citalopram—alcohol dependence	0.00232	0.00232	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Citalopram—alcohol dependence	0.00222	0.00222	CcSEcCtD
Deferoxamine—Urticaria—Citalopram—alcohol dependence	0.00215	0.00215	CcSEcCtD
Deferoxamine—Abdominal pain—Citalopram—alcohol dependence	0.00214	0.00214	CcSEcCtD
Deferoxamine—Body temperature increased—Citalopram—alcohol dependence	0.00214	0.00214	CcSEcCtD
Deferoxamine—Hypersensitivity—Citalopram—alcohol dependence	0.002	0.002	CcSEcCtD
Deferoxamine—Pruritus—Citalopram—alcohol dependence	0.00192	0.00192	CcSEcCtD
Deferoxamine—Diarrhoea—Citalopram—alcohol dependence	0.00185	0.00185	CcSEcCtD
Deferoxamine—Dizziness—Citalopram—alcohol dependence	0.00179	0.00179	CcSEcCtD
Deferoxamine—Vomiting—Citalopram—alcohol dependence	0.00172	0.00172	CcSEcCtD
Deferoxamine—Headache—Citalopram—alcohol dependence	0.0017	0.0017	CcSEcCtD
Deferoxamine—Nausea—Citalopram—alcohol dependence	0.00161	0.00161	CcSEcCtD
